Noreen Kamal | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.

Christian Messina | Neuromuscular Diseases | Best Researcher Award

Published on by Neuroscientists

Dr. Christian Messina | Neuromuscular Diseases | Best Researcher Award

Dr. Christian Messina, Azienda Sanitaria Provinciale Caltanissetta, Italy.

Dr. Christian Messina is an accomplished Italian neurologist with a strong academic foundation and a growing impact in the fields of neuromuscular diseases, demyelinating disorders, and dementia. He holds multiple advanced degrees and certifications in neurology and neurophysiology and is currently pursuing further specialization. Practicing across Sicily, he brings clinical expertise to both urban and regional settings. His research contributions, notably the identification of a novel hATTR variant and the use of eculizumab in myasthenic crisis, underscore his innovative approach to complex neurological conditions. With 12 high-impact publications and memberships in major neurological societies, Dr. Messina is a rising voice in Italian and international neuroscience.

Profile

orcid

Early Academic Pursuits

Dr. Christian Messina’s journey into the realm of neuroscience began with distinction at the University of Catania, where he completed his specialization in Neurology with honors. From the outset, his academic excellence set the tone for a career marked by precision, curiosity, and deep commitment to the neurological sciences. Driven by a passion for continuous learning, he later earned a Master’s degree in Adult and Geriatric Neuropsychology from the University of Chieti, and he is currently advancing his expertise through a second Master’s in Neurophysiology at the University of Milan.

Professional Endeavors in Neurology

Currently serving as a Dirigente Medico di I Livello at the Azienda Sanitaria Provinciale in Caltanissetta, Italy, Dr. Messina actively practices across multiple Sicilian provinces including Catania, Messina, Enna, and Siracusa. He undertook a six-month fellowship in neuromuscular disorders at the esteemed Neuromuscular Disease Center, University of Palermo, which sharpened his clinical acumen in diagnosing and managing complex neurological disorders. His work is deeply integrated into regional neurological care and remains pivotal in advancing both adult and pediatric neurophysiological diagnostics.

Contributions and Research Focus

Dr. Messina’s research is primarily focused on neuromuscular diseases, demyelinating CNS disorders such as multiple sclerosis, and dementia-related conditions. He has made significant contributions by identifying and clinically characterizing a novel hereditary transthyretin amyloidosis (hATTR) variant, and has proposed innovative therapies such as eculizumab in myasthenic crises. His work has also enhanced understanding of seronegative myasthenia gravis, adding valuable insight to the field. In his clinical publications, he often sheds light on rare genotypic and phenotypic presentations, offering clarity in diagnostic and therapeutic approaches.

Accolades and Recognition

With 12 peer-reviewed publications in high-impact SCI and Scopus-indexed journals, Dr. Messina has built a respected profile in academic neurology. His citation index—H-index 3 on Google Scholar, and 2 on Scopus and Web of Science—reflects the growing relevance of his scholarly contributions. He is also an active member of Italy’s foremost neurological societies including SIN, SINC, and LICE, through which he remains engaged in cutting-edge developments and collaborative scientific exchange.

Impact and Influence

Through his research on biological therapies in myasthenia gravis and the development of normative neurophysiological values for peripheral sensory nerve conduction, Dr. Messina has begun to influence how age-specific neurodiagnostic standards are developed globally. His clinical insights and research have the potential to improve diagnostic accuracy and treatment responses for patients across varying age groups. Furthermore, his documented work on rare variants not only expands medical literature but also enables precision medicine in neurology.

Innovation and Vision

Dr. Messina embodies a spirit of clinical innovation, demonstrated by his proactive application of novel therapeutics and diagnostic strategies. His current research continues to explore predictive markers for treatment response, bridging the gap between laboratory science and patient care. His vision is rooted in translating neurophysiological evidence into accessible, everyday clinical protocols that can be adopted widely in both primary and tertiary care settings.

Legacy and Future Contributions

Poised to become a thought leader in clinical neuroscience, Dr. Christian Messina’s dedication to rigorous research and compassionate practice is setting the foundation for a career of enduring impact. As he progresses toward completing his second master’s and expands his portfolio of publications, his work promises to shape the future of neurodiagnostics and neuromuscular care. His commitment to both the academic and clinical communities ensures that his contributions will continue to benefit patients, professionals, and scholars for years to come.

Publication

1. Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy
Authors: Maccora S., Vinciguerra C., Messina C., Bevilacqua L., Rini N., Barone P., Brighina F., Di Stefano V.
Year: 2025

2. Woodhouse-Sakati syndrome: A review
Author: Messina C.
Year: 2025

3. Prominent and fast response to eculizumab in myasthenic crisis: the potential as rescue therapy in refractory myasthenia gravis
Authors: Messina C., Basile L., Crescimanno G., Battaglia S., Scichilone N., Brighina F., Di Stefano V.
Year: 2025

4. Stroke Warning Syndrome as the Initial Manifestation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
Author: Messina C.
Year: 2025

5. Expanding the Genetic and Phenotypic Spectrum of Kearns-Sayre Syndrome: A Case Report
Author: Messina C.
Year: 2025

6. Woman with Breast Cancer Presenting with Opsoclonus–Myoclonus Syndrome: A Case Report and Literature Review
Authors: Cipolla C., Gebbia V., Di Stefano V., Messina C., Sambataro D., Brighina F., Mesi C., Greco M., Cortegiani A., Valerio M.R.
Year: 2025

7. Genetic Screening for Hereditary Transthyretin Amyloidosis in the Population of Cammarata and San Giovanni Gemini Through Red Flags and Registry Archives
Authors: Di Stefano V., Messina C., Pignolo A., Pecoraro F., Cutrò I., Alonge P., Rini N., Quartetti U., Lo Bue V., Borgione E., et al.
Year: 2025

8. A New Form of Combined Hyperactive Dysfunction Syndrome: A Unique Case
Author: Messina C.
Year: 2025

9. Expanding the Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis: The Glu61Ala Variant
Authors: Messina C., Gulizia S., Scalia F., Borgione E., Cappello F., Brighina F., Di Stefano V.
Year: 2025

10. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
Authors: Zanghì A., Avolio C., Signoriello E., Abbadessa G., Cellerino M., Ferraro D., Messina C., Barone S., Callari G., Tsantes E., et al.
Year: 2022

Conclusion

Dr. Messina represents a dynamic blend of clinical excellence and research innovation. His work has already made meaningful contributions to the understanding of rare neuromuscular conditions and therapeutic strategies. As he continues to pursue advanced training and lead impactful research, his influence in the field is expected to grow. He is a strong candidate for prestigious recognitions such as the Best Researcher Award or Excellence in Innovation Award, with the promise of making sustained contributions to neuroscience, clinical neurophysiology, and patient-centered neurological care in the years ahead.

Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

 

👨‍⚕️ Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

💼 Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

🔬 Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

🏆 Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

🌍 Impact and Influence

Dr. Gu Naibing’s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

🧠 Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

🌟 Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Gu’s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

  • Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
    Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
    Year: 2025

 

  • Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
    Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
    Year: 2025

 

Conclusion

Dr. Gu Naibing’s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

 

Zewen Cheng | Clinical Medicine | Young Scientist Award

Published on by Neuroscientists

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,  China.

Zewen Cheng’s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

 

🎓 Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

🏥 Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

🔬 Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

🏆 Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

💪 Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

🌟 Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

 

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

 

🏆 Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.

 

 

Dinh Phong Son | CircRNA | Best Researcher Award

Published on by Neuroscientists

Dr. Dinh Phong Son | CircRNA | Best Researcher Award

Dr. DINH PHONG SON, DUYTAN UNIVERSITY, Vietnam.

Dr. Dinh Phong Son is a researcher specializing in laboratory medicine techniques with a Ph.D. in Molecular Medicine from Guangxi Medical University, China. His research focuses on modern molecular biology techniques, particularly the identification of potential biomarkers for early disease diagnosis and targeted therapy. His studies explore systemic diseases such as diabetes, cardiovascular diseases, and cancer, emphasizing gene editing technologies like CRISPR/Cas9. His recent publications contribute to the understanding of regulatory RNA networks and their implications in disease mechanisms, providing a foundation for future studies on molecular interactions and targeted drug development.

Profile

Orcid

 

🎓 Early Academic Pursuits

From the very beginning of my academic journey, I was deeply fascinated by the intricate mechanisms of life at a molecular level. My pursuit of knowledge led me to study Laboratory Medicine Technique at Hue University of Medicine and Pharmacy, Vietnam, where I honed my expertise in diagnostic methodologies and medical laboratory sciences. With an insatiable thirst for discovery, I furthered my education by earning a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China. This academic foundation set the stage for my dedication to the field of molecular biology, shaping my vision to explore genetic markers and innovative diagnostic tools.

👩‍🎓 Professional Endeavors

Currently, I serve at Duy Tan University, College of Medicine and Pharmacy, where I actively contribute to research, mentoring, and academic discourse. My work primarily revolves around molecular diagnostics, genetic analysis, and disease biomarker identification, aiming to bridge the gap between molecular biology and clinical applications. With advancements in next-generation sequencing (NGS) and bioinformatics databases, I continually seek new pathways to enhance the precision of disease detection and treatment strategies.

🧪 Contributions and Research Focus

My research is deeply rooted in molecular medicine, focusing on the identification of potential biomarkers for the early diagnosis of systemic diseases such as diabetes, cardiovascular diseases, stroke, and cancer. My investigations also extend to exploring gene targets for pharmacological studies, assisting in drug development through the modulation of gene expression using cutting-edge technologies like CRISPR/Cas9, gene overexpression, and silencing approaches. Furthermore, my work delves into the complex LncRNA/CircRNA/miRNA/gene/protein-drug interaction networks, paving the way for theoretical models that could revolutionize targeted therapy research.

 

💎 Impact and Influence

The impact of my research extends beyond academia, as it plays a crucial role in early disease screening, personalized medicine, and therapeutic advancements. By leveraging molecular networks, I aim to facilitate the development of precise diagnostic tools and gene-targeted interventions, significantly improving patient outcomes. My research findings have the potential to reshape biomedical applications and create avenues for innovative treatment strategies across various diseases.

🌟 Legacy and Future Contributions

Looking ahead, my aspirations remain steadfast in expanding molecular biology research, particularly in uncovering novel biomarkers and refining gene-editing techniques. As the field continues to evolve, I hope to contribute to the refinement of therapeutic gene modifications and biomarker-based diagnostics. With sustained efforts and collaborations, I envision a future where my research serves as a cornerstone for breakthroughs in precision medicine, targeted gene therapy, and advanced molecular diagnostics.

👨‍💼 Professional Collaborations and Memberships

As an active member of the scientific community, I engage in collaborations and professional affiliations to foster knowledge exchange and multidisciplinary research. My involvement in editorial appointments, consultancy projects, and industry partnerships enables me to extend my research impact, ensuring that molecular medicine continues to advance for the benefit of humanity.

 

Publication

  • Title: Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on Microarray Data analysis, molecular docking, and dynamic simulation
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Hai-Anh Ha, Aigul Utegenova, Awais Ali, Abdulaziz Alamri
    Year: 2025

 

  • Title: Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Awais Ali, ShangLing Pan
    Year: 2024

 

  • Title: Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data
    Authors: ChauMyThanh Tran, PhongSon Dinh
    Year: 2024

 

  • Title: Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease
    Authors: PhongSon Dinh, JunHua Peng, ThanhLoan Tran, DongFeng Wu, ChauMyThanh Tran, ThiPhuongHoai Dinh, ShangLing Pan
    Year: 2023

 

  • Title: Construction of miRNAs and gene expression profiles associated with ischemic cardiomyopathy: Bioinformatics analysis
    Authors: PhongSon Dinh, Jun-Hua Peng, ChauMyThanh Tran, ThanhLoan Tran, Shang-Ling Pan
    Year: 2022

 

Conclusion

Dr. Son’s research plays a crucial role in advancing molecular biology by identifying key biomarkers and regulatory networks for disease screening and treatment. His work in gene-targeted therapy and RNA interaction networks lays the groundwork for future innovations in precision medicine. Despite challenges in resources and time, his commitment to molecular research aims to drive further advancements in understanding and treating complex diseases.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Ali Mehri | Neuroscience | Neuroscience Research Pioneer Award

Published on by Neuroscientists

Dr. Ali Mehri | Neuroscience | Neuroscience Research Pioneer Award

Dr. Ali Mehri Babol, Noshirvani University of Technology, Iran.

Dr. Ali Mehri is a prominent physicist whose academic journey has bridged the fields of solid-state physics, data science, and complex systems. With a Ph.D. in Solid State Physics from the University of Zanjan, his research explores novel interdisciplinary areas such as text mining, complex networks, and thermal and electronic transport in nanostructures. His work, particularly in the application of physical principles to data mining and linguistic studies, has significantly contributed to both theoretical and applied physics. Additionally, his research on the statistical properties of irrational numbers and the connection between Zipf’s exponent and language distribution has broadened the scope of complex systems analysis.

Profile

Google Scholar

Early Academic Pursuits 🎓

Dr. Ali Mehri began his academic journey in physics with a focus on solid-state physics. He completed his Bachelor’s degree in Solid State Physics at Kharazmi University in Tehran, Iran, in 2002. His passion for condensed matter physics led him to pursue a Master’s degree at the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, where he focused on colloidal monolayers in the presence of periodic light fields. Under the guidance of Professor Mir Faez Miri, he laid the foundation for his future research. In 2008, Dr. Mehri earned his Ph.D. in Solid State Physics from the University of Zanjan, where he studied the role of entropy in text mining under the supervision of Professor Amir Hossein Darooneh. This pivotal research provided him with a unique perspective that blends physics with data science.

Professional Endeavors 💼

After completing his education, Dr. Mehri embarked on a career in academia, where he has established himself as a dedicated educator and researcher. He currently serves as a faculty member at the Department of Physics, Babol Noshirvani University of Technology. His professional journey is marked by his deep involvement in research, teaching, and mentoring students, particularly in the fields of data and text mining, complex networks theory, and nanostructures. Over the years, he has collaborated with various national and international researchers, enhancing the global visibility of his work in these specialized areas of study.

Contributions and Research Focus 🔬

Dr. Mehri’s research interests lie at the intersection of physics and data science. His work on text mining using the Hurst exponent is a significant contribution to the emerging field of applying physical principles to analyze textual data. He has also explored the intriguing topic of irrational numbers by studying statistical distances to determine the order of digits. Furthermore, Dr. Mehri’s research extends to the correlation between Zipf’s exponent and the geographical distribution of human languages, which connects his expertise in complex networks theory with linguistics. His exploration of thermal and electronic transport in nanostructures adds a solid foundation to his contributions in condensed matter physics.

Accolades and Recognition 🏅

Throughout his academic career, Dr. Ali Mehri has received numerous accolades for his research contributions. His work, particularly in data mining and complex networks, has earned him recognition both in Iran and internationally. Dr. Mehri’s research has been cited in various scientific journals, showcasing the relevance and impact of his work in advancing knowledge within his fields. His academic achievements have solidified his reputation as a forward-thinking physicist who bridges the gap between theoretical and applied sciences.

Impact and Influence 🌍

Dr. Mehri’s work has had a profound impact on various scientific communities, particularly in the fields of data mining, complex networks, and nanostructures. By introducing concepts like the Hurst exponent to text mining and exploring the relationships between statistical distances and irrational numbers, his research has influenced not only physics but also the interdisciplinary applications of data science. His contributions to understanding the connection between language distribution and Zipf’s law have opened new avenues for researchers in both physics and linguistics, highlighting the diverse impact of his work across disciplines.

Legacy and Future Contributions 🕰️

As Dr. Mehri continues to push the boundaries of research, his legacy will be defined by his ability to merge complex concepts from physics with innovative methodologies from data science. His future contributions are expected to further enhance the understanding of nanostructures, electronic transport, and complex systems. Moreover, his pioneering work in text mining and the analysis of irrational numbers has the potential to lead to groundbreaking advancements in computational physics and data analytics. As his research evolves, Dr. Mehri’s work will undoubtedly inspire future generations of physicists and data scientists, reinforcing his lasting influence in these fields.

Publication

  • Title: The complex networks approach for authorship attribution of books
    Authors: A Mehri, AH Darooneh, A Shariati
    Year: 2012

 

  • Title: Variation of Zipf’s exponent in one hundred live languages: A study of the Holy Bible translations
    Authors: A Mehri, M Jamaati
    Year: 2017

 

  • Title: A nonextensive modification of the Gutenberg–Richter law: q-stretched exponential form
    Authors: AH Darooneh, A Mehri
    Year: 2010

 

  • Title: Word ranking in a single document by Jensen–Shannon divergence
    Authors: A Mehri, M Jamaati, H Mehri
    Year: 2015

 

  • Title: The role of entropy in word ranking
    Authors: A Mehri, AH Darooneh
    Year: 2011

 

  • Title: Keyword extraction by nonextensivity measure
    Authors: A Mehri, AH Darooneh
    Year: 2011

 

  • Title: Tsallis entropy, escort probability and the incomplete information theory
    Authors: AH Darooneh, G Naeimi, A Mehri, P Sadeghi
    Year: 2010

 

  • Title: Text mining by Tsallis entropy
    Authors: M Jamaati, A Mehri
    Year: 2018

 

  • Title: Power-law regularities in human language
    Authors: A Mehri, SM Lashkari
    Year: 2016

 

  • Title: Non-extensive distribution of human eye photoreceptors
    Authors: A Mehri
    Year: 2017

 

Conclusion

Dr. Mehri’s professional career, marked by teaching and research at Babol Noshirvani University of Technology, has earned him national and international recognition. His research continues to influence fields as diverse as data science, linguistics, and condensed matter physics. Looking ahead, his work promises to advance the understanding of nanostructures and foster the further integration of physics with computational and data sciences. Dr. Mehri’s legacy will likely continue to inspire future generations of scientists, underscoring the importance of interdisciplinary collaboration in driving scientific progress.

Sajad Hassanzadeh | Spinal cord injury | Best Researcher Award

Published on by Neuroscientists

Dr. Sajad Hassanzadeh | Spinal cord injury | Best Researcher Award

Dr. Sajad Hassanzadeh, Mayo clinic ,United States.

Dr. Sajad Hassanzadeh is a highly experienced researcher and academic based in Tehran, Iran. He holds a BSc in Nursing, a Master’s in Anatomical Sciences, and a Ph.D. in Anatomical Sciences from reputable Iranian universities. He has served as a Research Assistant at the Neuroscience Research Center and Eye Research Center at Iran University of Medical Sciences (IUMS). His research focuses on various areas of neuroscience, including spinal cord injury, neuropathic pain, and tissue engineering for neurological disorders.

 

profile

Scholar

 

🎓 Educational Background

BSc (2004-2008): Nursing, Iran University of Medical Sciences.Master (2010-2012): Anatomical Sciences, Tehran University of Medical Sciences.PhD (2013-2018): Anatomical Sciences, Iran University of Medical Sciences.

📚 Teaching Experience

Gross Anatomy (Nursing & Medical Students) 🩻 (2020–Present).Practical Courses in Human Dissection (Currently).Histology for Medical Students (2022).Workshops in Human Dissection (2020).

🌍 International Presentation

Keynote

🏢 Academic Information 

Position: Research Assistant.Institutions:Neuroscience Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran.Eye Research Center, Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS).

📊 Academic Metrics

H-index:Scholar: 11 (343 citations).Scopus: 10 (271 citations).ResearchGate: 10 (308 citations).

📚 Publications

  • Development of chitosan/hyaluronic acid hydrogel scaffolds via enzymatic reaction for cartilage tissue engineering
    • Authors: SM Davachi, SMA Haramshahi, SA Akhavirad, N Bahrami, …
    • Year: 2022

 

  • Enzymatic crosslinked hydrogels for biomedical application
    • Authors: E Badali, M Hosseini, M Mohajer, S Hassanzadeh, S Saghati, J Hilborn, …
    • Year: 2021

 

  • Control of cellular adhesiveness in hyaluronic acid‐based hydrogel through varying degrees of phenol moiety cross‐linking
    • Authors: S Bagheri, Z Bagher, S Hassanzadeh, S Simorgh, SK Kamrava, …
    • Year: 2021

 

  • Combined effects of rat Schwann cells and 17β-estradiol in a spinal cord injury model
    • Authors: Z Namjoo, F Moradi, R Aryanpour, A Piryaei, MT Joghataei, Y Abbasi, …
    • Year: 2018

 

  • More attention on glial cells to have better recovery after spinal cord injury
    • Authors: S Hassanzadeh, M Jalessi, SB Jameie, M Khanmohammadi, Z Bagher, …
    • Year: 2021

 

  • Coenzyme Q10 influences on the levels of TNF-α and IL-10 and the ratio of Bax/Bcl2 in a menopausal rat model following lumbar spinal cord injury
    • Authors: S Hassanzadeh, SB Jameie, M Soleimani, M Farhadi, M Kerdari, …
    • Year: 2018

 

  • Alginate sulfate/ECM composite hydrogel containing electrospun nanofiber with encapsulated human adipose-derived stem cells for cartilage tissue engineering
    • Authors: R Najafi, H Chahsetareh, M Pezeshki-Modaress, M Aleemardani, …
    • Year: 2023

 

  • FNDC5 expression in Purkinje neurons of adult male rats with acute spinal cord injury following treatment with methylprednisolone
    • Authors: S Hassanzadeh, SB Jameie, M Mehdizadeh, M Soleimani, Z Namjoo, …
    • Year: 2018

 

Conclusion

Dr. Sajad Hassanzadeh is a dedicated researcher and educator in the field of anatomical sciences and neuroscience. His work in tissue engineering and cell therapy for spinal cord injuries has the potential to significantly impact regenerative medicine. Through his ongoing research projects, teaching contributions, and supervision of graduate students, he continues to make strides in advancing the understanding and treatment of neurological disorders. His collaboration in multiple international research projects and successful grant acquisition showcases his dedication to scientific progress in medical and neuroscience fields.

 

 

Rahim Mohammadi | Regenerativ Medicine | Best Researcher Award

Published on by Neuroscientists

Assit prof Dr.Rahim Mohammadi | Regenerativ Medicine | Best Researcher Award

Assoc Prof Dr. Rahim Mohammadi Urmia University Iran

Dr. Rahim Mohammadi, D.V.M, D.V.Sc, D.I.hom, is a highly experienced Associate Professor of Veterinary Surgery at Urmia University, Iran. With over two decades of academic and clinical experience, he has significantly contributed to the field of veterinary surgery and diagnostic imaging. His educational background includes a Doctor of Veterinary Medicine (DVM) and specialized training in homeopathy from London. Dr. Mohammadi’s extensive experience includes a board certification in veterinary surgery and years of dedicated service as both an Assistant and Associate Professor.

 

profile

google scholar

🎓 Education & Professional Experiences

2019-Present: Associate Professor of Veterinary SurgeryDept. Surgery and Diagnostic Imaging, Faculty of Veterinary Medicine, Urmia University.2011-2019: Assistant Professor of Veterinary Surgery.Dept. Surgery and Diagnostic Imaging, Faculty of Veterinary Medicine, Urmia University2010: Board Certification in Veterinary Surgery.Urmia University, Urmia, Iran.2006-2010: Residency in Veterinary Surgery.Dept. Surgery and Diagnostic Imaging, Faculty of Veterinary Medicine, Urmia University.1990-1996: DVM, IAU, Urmia Branch, Urmia, Iran.1995-1997: DIhom, The British Institute of Homeopathy, Homeopathic Medicine, London, United Kingdom

 

🏅 Professional Roles & Memberships

2017-Present: Board Certifying Examination Committee, Faculty of Veterinary Medicine, Urmia University.2010-Present: Language Editor, Veterinary Research Forum.2021-Present: Editorial Board Member, Iranian Journal of Veterinary Surgery.

 

💼 Scientific Memberships

Member of International Brain Research Organization.Member of Federation of Asian and Oceanian Neuroscience Societies.Member of Iranian Neuroscience SocietyMember of World Veterinary Association.Member of Iranian Veterinary Council.Member of Iranian Veterinary Surgery Association.Member of Iranian Homeopathy Association

 

📚 Publications

  • Surgical repair and management of congenital intestinal atresia in 68 calves
    S. Azizi, R. Mohammadi, I. Mohammadpour (2010)

 

  • Dexamethasone topically accelerates peripheral nerve repair and target organ reinnervation: a transected sciatic nerve model in rat
    R. Mohammadi, M. Azad-Tirgan, K. Amini (2013)

 

  • Comparison of beneficial effects of undifferentiated cultured bone marrow stromal cells and omental adipose‐derived nucleated cell fractions on sciatic nerve regeneration
    R. Mohammadi, S. Azizi, N. Delirezh, R. Hobbenaghi, K. Amini (2011)

 

  • Effects of undifferentiated cultured omental adipose-derived stem cells on peripheral nerve regeneration
    R. Mohammadi, S. Azizi, K. Amini (2013)

 

  • Pulsed electromagnetic fields accelerate functional recovery of transected sciatic nerve bridged by chitosan conduit: an animal model study
    R. Mohammadi, D. Faraji, H. Alemi, A. Mokarizadeh (2014)

 

  • Transplantation of uncultured omental adipose-derived stromal vascular fraction improves sciatic nerve regeneration and functional recovery through inside-out vein graft in rats
    R. Mohammadi, S. Azizi, N. Delirezh, R. Hobbenaghi, K. Amini (2012)

 

  • Influence of tacrolimus (FK506) on nerve regeneration using allografts: a rat sciatic nerve model
    M. Shahraki, R. Mohammadi, A. Najafpour (2015)

 

  • Vascular endothelial growth factor promotes peripheral nerve regeneration after sciatic nerve transection in rat
    M. Rahim, A. Sima, M. Masoume, A. Keyvan (2013)

 

  • The Extract of Lycium depressum Stocks Enhances Wound Healing in Streptozotocin-Induced Diabetic Rats
    S. Naji, L. Zarei, M. Pourjabali, R. Mohammadi (2017)

 

  • Protective effects of intraperitoneal administration of nimodipine on ischemia–reperfusion injury in ovaries: Histological and biochemical assessments in a rat model
    T. Behroozi-Lak, L. Zarei, M. Moloody–Tapeh, N. Farhad, R. Mohammadi (2017)

Conclusion

Dr. Rahim Mohammadi’s academic and professional journey showcases a deep commitment to advancing veterinary surgery and diagnostic imaging. His multidisciplinary expertise, backed by a wealth of research and editorial experience, positions him as a leader in his field. His active involvement in international research organizations further highlights his dedication to knowledge-sharing and veterinary medicine advancements.

 

 

Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Published on by Neuroscientists

Mr.Hamid khan | Molecular and Cellular Neuroscience | Young Scientist Award

Mr. Hamid khan Icahn School of Medicine at Mount Sinai, New York Pakistan

Hamid Khan is a dedicated researcher and educator who recently completed his PhD in Biotechnology, specializing in Human Molecular Genetics. His academic journey includes a strong foundation in biological sciences, evidenced by his educational background ranging from a BSc to a PhD, with a focus on genetic analysis of rare congenital disorders. His doctoral research has provided insights into the genetic basis of autism spectrum disorder (ASD) and oculocutaneous albinism, contributing significantly to the understanding of these conditions.

profile

scholar

🎓 Education

PhD in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan & University of Toronto, Canada (2018-2024).MS/M.Phil in Biotechnology (Human Molecular Genetics)International Islamic University Islamabad, Pakistan (2016-2018).M.Sc in ZoologyHazara University Mansehra, KPK, Pakistan (2011-2013).B.Sc in Biological Science (Botany, Zoology, Chemistry)University of Peshawar, Pakistan (2008-2010).H.S.S.C Pre-Medical
Peshawar Board, Pakistan (2006-2008)S.S.C Science SubjectsPeshawar Board, Pakistan (2004-2006).B.Ed in Education
Sarhad University of Science & Information Technology (2014).CT Certified TeacherAllama Iqbal Open University (2016).

🔬 Research Experience

Researcher at Biomolecular Genetic Engineering Lab, International Islamic University Islamabad (4 years).Research Associate in Pak-US Science and Technology Cooperation Program (1 year).Researcher in MiND Laboratory, Campbell Family Mental Health Research Institute, Toronto, Canada (6 months)

💼 Work Experience

Visiting Lecturer at Department of Biological Sciences, IIUI (3 years).Lecturer at IQRA College of Technology, IIUI (2 years)

 

🛠️ Skills

Laboratory Skills: PCR, NGS data analysis, Microarray, Gene Cloning, Cell Culturing, etc.Computer Skills: Python, Sentieon, Verseq, Exomiser, Excel, PowerPoint, Word.

🏆 Awards

IRSIP Award from the Higher Education Commission (HEC) Pakistan.First position holder in PhD coursework.Selected as Research Associate in a Pak-US project.

🌍 Collaborations

Currently working with three international and several national collaborations.

📚 Publications

  1. Title: Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder
    Authors: Hamid Khan, Ricardo Harripaul, Anna Mikhailov, Sumayah Herzi, …
    Year: 2024

 

  1. Title: Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder
    Authors: Lettie E Rawlins, Reza Maroofian, Stuart J Cannon, Muhannad Daana, Mina Zamani, Shamsul Ghani, …
    Year: 2024

 

  1. Title: Nigella sativa extract abrogates traumatic brain injury-induced memory impairment in adult mice
    Authors: RU Khan, SM Jawad, MM Kiyani, SA Shah, S Bashir, Hamid Khan
    Year: 2024

 

  1. Title: Mutational spectrum associated with oculocutaneous albinism and Hermansky-Pudlak syndrome in nine Pakistani families
    Authors: J Khan, S Asif, S Ghani, Hamid Khan, MW Arshad, SA Khan, S Lin, EL Baple, …
    Year: 2024

 

  1. Title: An Update on Recent Advancement in Autism Spectrum Disorder Treatment Strategies
    Authors: Hamid Khan, M Uzair, H Riaz, B Khan, MI Shabbir
    Year: 2023

Conclusion

Hamid Khan’s profile illustrates a strong commitment to advancing the field of biotechnology through research and education. His focus on the genetic underpinnings of rare disorders positions him as a valuable contributor to both academic and clinical settings. With a proven track record of research publications and collaborative projects, he is poised to make significant impacts in the realm of human genetics and molecular biology. His dedication to teaching and nurturing student curiosity further underscores his potential as an educator and mentor. As he seeks new opportunities, his combination of technical expertise, research experience, and passion for education will undoubtedly enable him to excel and inspire in any dynamic academic or research environment.